DE1901519A1 - Chinazolinylharnstoffe - Google Patents

Chinazolinylharnstoffe

Info

Publication number
DE1901519A1
DE1901519A1 DE19691901519 DE1901519A DE1901519A1 DE 1901519 A1 DE1901519 A1 DE 1901519A1 DE 19691901519 DE19691901519 DE 19691901519 DE 1901519 A DE1901519 A DE 1901519A DE 1901519 A1 DE1901519 A1 DE 1901519A1
Authority
DE
Germany
Prior art keywords
carbon atoms
formula
alkyl
hydrogen
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691901519
Other languages
German (de)
English (en)
Inventor
Hess Hans-Juergen Ernst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE1901519A1 publication Critical patent/DE1901519A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19691901519 1968-02-02 1969-01-14 Chinazolinylharnstoffe Pending DE1901519A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70253468A 1968-02-02 1968-02-02

Publications (1)

Publication Number Publication Date
DE1901519A1 true DE1901519A1 (de) 1969-08-28

Family

ID=24821601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691901519 Pending DE1901519A1 (de) 1968-02-02 1969-01-14 Chinazolinylharnstoffe

Country Status (6)

Country Link
US (1) US3574212A (zh)
BE (1) BE726984A (zh)
DE (1) DE1901519A1 (zh)
FR (1) FR2001171A1 (zh)
GB (1) GB1195932A (zh)
SE (1) SE358166B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597479A1 (fr) * 1986-03-13 1987-10-23 Kotobuki Seiyaku Co Ltd Derives de la quinazoline utilises comme agents anti-hypertensifs, et procede de preparation de ces composes.

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723434A (en) * 1970-07-17 1973-03-27 Pfizer Piperazino isoquinoline bronchodilators
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives
JPS536156B2 (zh) * 1972-10-30 1978-03-04
JPS5793977A (en) * 1980-11-26 1982-06-11 Sankyo Co Ltd Acylaminoquinazoline derivative and its preparation
CS236097B1 (en) * 1983-06-01 1985-05-15 Jan Koenig Acylderivatives of 2-piperazinochinazoline and method of their preparation
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597479A1 (fr) * 1986-03-13 1987-10-23 Kotobuki Seiyaku Co Ltd Derives de la quinazoline utilises comme agents anti-hypertensifs, et procede de preparation de ces composes.

Also Published As

Publication number Publication date
BE726984A (zh) 1969-07-16
SE358166B (zh) 1973-07-23
US3574212A (en) 1971-04-06
GB1195932A (en) 1970-06-24
FR2001171A1 (zh) 1969-09-26

Similar Documents

Publication Publication Date Title
DE2734070C2 (de) Aminoalkylfuranderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69219394T2 (de) Heterozyklische Alkylamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2800954A1 (de) Derivate des meta-trifluoromethylphenylpiperazins und deren verwendung als arzneimittel
DE2502397A1 (de) Guanidinderivate, ein verfahren zu deren herstellung sowie arzneimittel
DE1901519A1 (de) Chinazolinylharnstoffe
DE2631885C2 (de) 1-(4-Phenoxyphenyl)-piperazin-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE69419517T2 (de) Benzazole derivate als therapeutische mittel
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
AT344151B (de) Verfahren zur herstellung von neuen naphthalinderivaten
DE69007422T2 (de) 1-(4-Aminophenyl)-2-piperidinopropanon-Derivate, Verfahren zu deren Herstellung und therapeutische Verwendung.
DE2107871C3 (zh)
DE2034640C3 (de) l-p-(7-Trifluormethyl-4-chinolyl) -amino-benzoyl-piperazine, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Bluthochdruck
DE3121175A1 (de) Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2624918A1 (de) Arzneimittel mit antiarrhythmischer wirkung
DE2166662C3 (de) Dibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2000775B2 (de) Substituierte 1,2,3,4-Tetrahydrobenzothieno [23-c] pyridin-Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung, die diese Verbindungen enthält
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2357320C3 (de) 3-Metnyl-8-methoxy-(3H)-l,2,5.6tetrahydropyrazino- [1,23-ab] - ß -carbolin, seine Salze sowie ein Verfahren zu deren Herstellung und Arzneimittel
DE2145682C3 (de) 1,4-disubstituierte Piperazin-Derivate und deren Säureadditionsverbindungen
DE3012190A1 (de) Pharmazeutisches mittel auf der basis 1,3,5-substituierter biuret-verbindungen
DE2053205A1 (de) Dihydrofurandenvate und Verfahren zu deren Herstellung
DE2024045A1 (de) Derivate von Dibenzo(a,d)-5Hcyclohepten
DE69523346T2 (de) Substituierte 6-h-1,3,4-thiadiazin-2-amine, deren verwendung als anaesthetisierende cardiovaskulare und hypometabole mittel, und eine sie enthaltende pharmazeutische zubereitung
CH615181A5 (en) Process for the preparation of novel ergolene derivatives
DE2022790C3 (de) 10-Methyl-5-[ (4-Methylpiperazino)-acetyl J-5,10dihydro-llH-dibenzo [b,e ] [1,4 ] diazepin-11-on, ein Verfahren zu dessen Herstellung sowie dieses enthaltende Arzneimittel